2m 2m 2m 2m 2m 2m 2m
KODIAK SCIENCES (KOD)
NASDAQ
$37.00+$0.37 (+1.01%)
Price as of Jun 23, 2026 5:07 PM EDT- $2.3BMarket Cap
- 909.09%1-Year Change
- BiotechnologyIndustry
KODIAK SCIENCES (KOD)
$37.00+$0.37 (+1.01%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -182.4M +44.63% | -126.1M -38.88% | -206.3M -22.91% | -267.6M +23.12% | |
Depreciation and Amortization Expense | 18.3M -2.04% | 18.7M +2.25% | 18.3M +382.03% | 3.8M +278.46% | |
Total Operating Expenses | 234.4M +25.44% | 186.8M -32.62% | 277.3M -18.76% | 341.4M +27.83% | |
Operating Profit | -234.4M +25.44% | -186.8M -32.62% | -277.3M -18.76% | -341.4M +27.83% | |
Interest Income | 4.5M -59.48% | 11.1M -33.38% | 16.7M +136.64% | 7.1M +2,272.82% | |
Interest Expense | 0 N/A | 0 +100.00% | -13,000 -27.78% | -18,000 -18.18% | |
Interest Income and Expense and Net | 4.5M -59.48% | 11.1M -33.33% | 16.7M +137.06% | 7.1M +2,455.43% | |
Total Nonoperating Income and Expense | -96,000 -81.03% | -506,000 -560.00% | 110,000 -78.13% | 503,000 +333.95% | |
Income before Taxes | -234.4M +25.44% | -186.8M -32.62% | -277.3M -18.76% | -341.4M +27.83% | |
Income Taxes | 52,000 +160.00% | 20,000 -39.39% | 33,000 0.00% | 33,000 -55.41% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -230.0M +30.51% | -176.2M -32.36% | -260.5M -21.97% | -333.8M +25.03% | |
Net Income from Continuing Operations Applicable to Common | -230.0M +30.51% | -176.2M -32.36% | -260.5M -21.97% | -333.8M +25.03% | |
Basic EPS and Net Income | -4.32 +28.96% | -3.35 -32.60% | -4.97 -22.22% | -6.39 +23.84% | |
Diluted EPS and Net Income | -4.32 +28.96% | -3.35 -32.60% | -4.97 -22.22% | -6.39 +23.84% | |
Basic Weighted Average Shares | 53.2M +1.19% | 52.6M +0.32% | 52.4M +0.32% | 52.2M +0.89% | |
Diluted Weighted Average Shares | 53.2M +1.19% | 52.6M +0.32% | 52.4M +0.32% | 52.2M +0.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 209.9M +24.86% | 168.1M -41.13% | 285.5M +49.93% | 190.4M -73.97% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 288.5M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 209.9M +24.86% | 168.1M -41.13% | 285.5M -40.39% | 478.9M -34.53% | |
Total Current Assets | 214.8M +24.94% | 171.9M -40.57% | 289.3M -40.47% | 486.0M -33.86% | |
Accumulated Depreciation | 59.5M +44.13% | 41.3M +82.96% | 22.6M +235.40% | 6.7M +128.79% | |
Property and Plant and Equipment and Net | 85.3M -16.60% | 102.2M -15.16% | 120.5M +113.68% | 56.4M +36.42% | |
Total Long-Term Assets | 8.7M -0.68% | 8.7M +0.14% | 8.7M -85.11% | 58.5M +6.43% | |
Total Assets | 351.5M +4.75% | 335.6M -30.00% | 479.4M -28.09% | 666.6M -26.28% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 45.5M +78.05% | 25.6M -38.72% | 41.7M -20.51% | 52.5M -18.84% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 47.1M -21.10% | 59.7M N/A | 0 -100.00% | 162,000 -23.22% | |
Total Liabilities | 194.2M +4.78% | 185.3M -13.25% | 213.6M -7.32% | 230.5M -4.33% | |
Retained Earnings | -1.6B +17.31% | -1.3B +15.29% | -1.2B +29.20% | -892.0M +59.80% | |
Total Stockholders Equity | 157.4M +4.72% | 150.3M -43.45% | 265.8M -39.06% | 436.2M -34.24% | |
Total Shares Outstanding | 61.8M +17.62% | 52.5M 0.00% | 52.5M +0.33% | 52.3M +0.98% | |
Cash Flow | |||||
Cash from Operating Activities | -136.0M +15.93% | -117.3M -23.91% | -154.2M -25.32% | -206.5M +13.27% | |
Capital Expenditures | 506,000 +34.93% | 375,000 -99.09% | 41.4M +11.69% | 37.0M +117.36% | |
Cash from Investing Activities | -506,000 -32.98% | -755,000 -100.30% | 249.2M +174.06% | -336.5M +767.35% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 178.3M +35,489.22% | 501,000 +1,516.13% | 31,000 -98.36% | 1.9M -76.84% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -66.94% +54.79% | -43.24% -4.88% | -45.46% +6.96% | -42.50% +56.93% | |
Return on Equity | -149.49% +76.49% | -84.70% +14.12% | -74.22% +22.23% | -60.72% +73.32% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 4.72 -29.83% | 6.72 -3.02% | 6.93 -25.11% | 9.26 -18.51% | |
Cash Ratio | 4.61 -29.87% | 6.57 -3.94% | 6.84 +88.61% | 3.63 -67.92% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow